Skip to main content
Equibles

Alan Holmer

Board Member

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Alan Holmer

Alan Holmer is recorded as Board Member at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed December 18, 2025 that Alan Holmer retired as Board of Directors, effective December 31, 2025. Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 20, 2024 that Alan Holmer was appointed director, effective May 16, 2024.

“On December 12, 2025, Alan Holmer provided Corbus Pharmaceuticals Holdings, Inc. (the “Company”) with notice of his resignation from the Board of Directors, effective December 31, 2025, due to retirement.”
Corbus Pharmaceuticals Holdings, Inc. Form 8-K, filed December 18, 2025 · Read the filing
“The election of each of Yuval Cohen, Alan Holmer, Avery W. Catlin, Rachelle Jacques, John Jenkins, Peter Salzmann, Anne Altmeyer and Yong Ben as directors to hold office for a term of one year, until his or her successor is duly elected and qualified or he or she is otherwise unable to complete his or her term.”
Corbus Pharmaceuticals Holdings, Inc. Form 8-K, filed May 20, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Corbus Pharmaceuticals Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.